Lara Ionescu Silverman, Ph.D.

Lara Ionescu Silverman, Ph.D.

Principal Consultant
LIS BioConsulting
Cell & Gene Therapy Review Editorial Advisory Board Member

Lara has deep expertise leading translational development activities for cell and gene therapies. She combines nuanced understanding of the scientific, clinical and commercial landscapes to drive a company’s strategic decisions. Her scientific development experience includes process design, analytical methods, raw materials, lab operations, intellectual property, regulatory interactions, and outward-facing communications. She has overseen multi-functional, multi-layered teams and has developed plans and strategies with both short- and long-term implications for businesses. Her work has resulted in numerous peer-reviewed manuscripts and presentations at academic and industry conferences, as well as issued patents. She earned a BSE in Chemical Engineering from Princeton and a Ph.D. in Bioengineering from University of Pennsylvania.

Articles by Lara Ionescu Silverman, Ph.D.

  • CBER director offers a candid take on industry challenges

    Tuesday, October 06, 2026
    During the keynote at ARM’s Meeting on the Mesa, Karim Mikhail, recently selected to lead CBER after serving as the center’s acting director, offered a candid look at the challenges regulators face in accelerating the development of innovative cell and gene therapies for rare diseases.